GB virus C (GBV-C) infection in hepatitis C virus (HCY)/HIV-coinfected patients receiving HCV treatment: Importance of the GBV-C genotype

Journal of Infectious Diseases

Volumn 194, Issue 4, 2006, Pages 410-419

  Schwarze Zander, Carolynne ^a,c   Blackard, Jason T ^c   Zheng, Hui ^d   Addo, Marylyn M ^c   Lin, Wenyu ^c   Robbins, Gregory K ^c   Sherman, Kenneth E ^e   Zdunek, Dietmar ^b   Hess, Georg ^b   Chung, Raymond T ^c  

^a UNIVERSITY OF BONN   (Germany)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INTERFERON; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY E2; PEGINTERFERON; RIBAVIRIN; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; ANTIBODY DETECTION; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS G; HEPATITIS G VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIREMIA; VIRUS GENOME; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; GB VIRUS C; GENOTYPE; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; INTERFERONS; MALE; MASSACHUSETTS; PREVALENCE; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 33746712863     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/505713     Document Type: Article

References (52)

1. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995; 1:564-9.
2. Linnen J, Wages J Jr, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271:505-8.
3. Bowden S, McCaw R, White PA, Crofts N, Aitken CK. Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users. J Viral Hepat 2005; 12:322-4.
4. Masuko K, Mitsui T, Iwano K, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996; 334:1485-90.
5. Dille BJ, Surowy TK, Gutierrez RA, et al. An ELISA for detection of antibodies to the E2 protein of GB virus C. J Infect Dis 1997; 175:458-61.
6. Tacke M, Schmolke S, Schlueter V, et al. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. Hepatology 1997; 26:1626-33.
7. Hassoba HM, Pessoa MG, Terrault NA, et al. Antienvelope antibodies are protective against GBV-C reinfection: evidence from the liver transplant model. J Med Virol 1998; 56:253-8.
8. Thomas DL, Vlahov D, Alter HJ, et al. Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J Infect Dis 1998; 177:539-42.
9. Lefrère J-J, Roudot-Thoraval F, Morand-Joubert L, et al. Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis 1999; 179:783-9.
10. Xiang J, Wunschmann S, Diekema DJ, et al. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 2001; 345:707-14.
11. Tillmann H, Heiken H, Knapik-Botor A, et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 2001; 345:715-24.
12. Yeo AE, Matsumoto A, Hisada M, Shih JW, Alter HJ, Goedert JJ. Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter Hemophilia Cohort Study. Ann Intern Med 2000; 132:959-63.
13. Birk M, Lindback S, Lidman C. No influence of GB virus C replication on the prognosis in a cohort of HIV-1-infected patients. AIDS 2002; 16:2482-5.
14. Bjorkman P, Flamholc L, Naucler A, Molnegren V, Wallmark E, Widell A. GB virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality. AIDS 2004; 18:877-86.
15. Brumme ZL, Chan KJ, Dong WW, et al. No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy. AIDS 2002; 16:1929-33.
16. Lau DT-Y, Miller KD, Detmer J, et al. Hepatitis G virus and human immunodeficiency virus coinfection: response to interferon-α therapy. J Infect Dis 1999; 180:1334-7.
17. Tanaka E, Alter HJ, Nakatsuji Y, et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med 1996; 125:740-3.
18. Tanaka T, Hess G, Schlueter V, Zdunek D, Tanaka S, Kohara M. Correlation of interferon treatment response with GBV-C/HGV genomic RNA and anti-envelope 2 protein antibody. J Med Virol 1999; 57:370-5.
19. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999; 30:1054-8.
20. Pineda JA, Macias J. Progression of liver fibrosis in patients coinfected with hepatitis C virus and human immunodeficiency virus undergoing antiretroviral therapy. J Antimicrob Chemother 2005; 55:417-9.
21. Soto B, Sanchez-Quijano A, Rodrigo L, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997; 26:1-5.
22. Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001; 32:492-7.
23. Giordano TP, Kramer JR, Souchek J, Richardson P, El-Serag HB. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Arch Intern Med 2004; 164:2349-54.
24. Carrat F, Bani-Sadr F, Pol S, et al. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 2004; 292:2839-48.
25. Chung R, Andersen J, Volberding P, et al. Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med 2004; 351:451-9.
26. Torriani F, Rodriguez-Torres M, Rockstroh J, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 2004; 351:438-50.
27. Katayama K, Kageyama T, Fukushi S, et al. Full-length GBV-C/HGV genomes from nine Japanese isolates: characterization by comparative analyses. Arch Virol 1998; 143:1063-75.
28. Muerhoff AS, Leary TP, Sathar MA, Dawson GJ, Desai SM. African origin of GB virus C determined by phylogenetic analysis of a complete genotype 5 genome from South Africa. J Gen Virol 2005; 86:1729-35.
29. Muerhoff AS, Simons JN, Erker JC, Desai SM, Mushahwar IK. Identification of conserved nucleotide sequences within the GB virus C 5′-untranslated region: design of PCR primers for detection of viral RNA. J Virol Methods 1996; 62:55-62.
30. Muerhoff AS, Smith DB, Leary TP, Erker JC, Desai SM, Mushahwar IK. Identification of GB virus C variants by phylogenetic analysis of 5′-untranslated and coding region sequences. J Virol 1997; 71:6501-8.
31. Mukaide M, Mizokami M, Orito E, et al. Three different GB virus C/hepatitis G virus genotypes: phylogenetic analysis and a genotyping assay based on restriction fragment length polymorphism. FEBS Lett 1997; 407:51-8.
32. Okamoto H, Nakao H, Inoue T, et al. The entire nucleotide sequences of two GB virus C/hepatitis G virus isolates of distinct genotypes from Japan. J Gen Virol 1997; 78:737-45.
33. Tucker TJ, Smuts H, Eickhaus P, Robson SC, Kirsch RE. Molecular characterization of the 5′ non-coding region of South African GBV-C/HGV isolates: major deletion and evidence for a fourth genotype. J Med Virol 1999; 59:52-9.
34. Tucker TJ, Smuts HE. GBV-C/HGV genotypes: proposed nomenclature for genotypes 1-5. J Med Virol 2000; 62:82-3.
35. Ishak R, Zakaria Z. Detection of carrier status of hemophilia B using DNA markers. Southeast Asian J Trop Med Public Health 1997; 28:629-30.
36. Schlueter V, Schmolke S, Stark K, Hess G, Ofenloch-Haehnle B, Engel AM. Reverse transcription-PCR detection of hepatitis G virus. J Clin Microbiol 1996; 34:2660-4.
37. Thompson J, Gibson T, Plewniak F, Jeanmougin F, Higgins D. The CLUSTAL X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997; 25:4876-82.
38. Bourlet T, Guglielminotti C, Evrard M, et al. Prevalence of GBV-C/hepatitis G virus RNA and E2 antibody among subjects infected with human immunodeficiency virus type 1 after parenteral or sexual exposure. J Med Virol 1999; 58:373-7.
39. Nerurkar VR, Chua PK, Hoffmann PR, Dashwood WM, Shikuma CM, Yanagihara R. High prevalence of GB virus C/hepatitis G virus infection among homosexual men infected with human immunodeficiency virus type 1: evidence for sexual transmission. J Med Virol 1998; 56:123-7.
40. Francesconi R, Giostra F, Ballardini G, et al. Clinical implications of GBV-C/HGV infection in patients with "HCV-related" chronic hepatitis. J Hepatol 1997; 26:1165-72.
41. Van der Bij AK, Kloosterboer N, Prins M, et al. GB virus C coinfection and HIV-1 disease progression: the Amsterdam Cohort Study. J Infect Dis 2005; 191:678-85.
42. Williams CF, Klinzman D, Yamashita TE, et al. Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 2004; 350:981-90.
43. Nubling CM, Bialleck H, Fursch AJ, et al. Frequencies of GB virus C/hepatitis G virus genomes and of specific antibodies in German risk and non-risk populations. J Med Virol 1997; 53:218-24.
44. Kao JH, Lai MY, Chen W, Chen PJ, Chen DS. Efficacy of ribavirin plus interferon alpha on viraemia of GB virus-C/hepatitis G virus: comparison with interferon alpha alone. J Gastroenterol Hepatol 1998; 13:1249-53.
45. Marrone A, Shih JW, Nakatsuji Y, et al. Serum hepatitis G virus RNA in patients with chronic viral hepatitis. Am J Gastroenterol 1997; 92:1992-6.
46. Heringlake S, Ockenga J, Tillmann HL, et al. GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis 1998; 177:1723-6.
47. Nattermann J, Nischalke HD, Kupfer B, et al. Regulation of CC chemokine receptor 5 in hepatitis G virus infection. AIDS 2003; 17:1457-62.
48. Nunnari G, Nigro L, Palermo F, et al. Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile. Ann Intern Med 2003; 139:26-30.
49. Xiang J, George SL, Wunschmann S, Chang Q, Klinzman D, Stapleton JT. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Lancet 2004; 363:2040-6.
50. Kaye S, Howard M, Alabi A, Hansmann A, Whittle H, Schim van der Loeff M. No observed effect of GB virus C coinfection on disease progression in a cohort of African woman infected with HIV-1 or HIV-2. Clin Infect Dis 2005; 40:876-8.
51. Muerhoff A, Tillmann H, Manns M, Dawson G, Desai S. GB virus C genotype determination in GB virus-C/HIV co-infected individuals. J Med Virol 2003; 70:141-9.
52. Berzsenyi MD, Bowden DS, Roberts SK. GB virus C: insights into coinfection. J Clin Virol 2005; 33:257-66.